Zhang Y - Search Results

1

Metabolic Reprogramming via ACOD1 depletion enhances function of human induced pluripotent stem cell-derived CAR-macrophages in solid tumors.

Wang X, Su S, Zhu Y, Cheng X, Cheng C, Chen L, Lei A, Zhang L, Xu Y, Ye D, Zhang Y, Li W, Zhang J. Wang X, et al. Among authors: zhang l, zhang j, zhang y. Nat Commun. 2023 Sep 18;14(1):5778. doi: 10.1038/s41467-023-41470-9. Nat Commun. 2023. PMID: 37723178 Free PMC article.

2

Single cell profiling of female breast fibroadenoma reveals distinct epithelial cell compositions and therapeutic targets.

Chen Z, Zhang Y, Li W, Gao C, Huang F, Cheng L, Jin M, Xu X, Huang J. Chen Z, et al. Among authors: zhang y. Nat Commun. 2023 Jun 16;14(1):3469. doi: 10.1038/s41467-023-39059-3. Nat Commun. 2023. PMID: 37328469 Free PMC article.

3

Safety and efficacy of jaktinib in the treatment of Janus kinase inhibitor-naïve patients with myelofibrosis: Results of a phase II trial.

Zhang Y, Zhou H, Jiang Z, Wu D, Zhuang J, Li W, Jiang Q, Wang X, Huang J, Zhu H, Yang L, Du X, Li F, Xia R, Zhang F, Hu J, Li Y, Hu Y, Liu J, Jin C, Sun K, Zhou Z, Wu L, Yu W, Jin J. Zhang Y, et al. Among authors: zhang f. Am J Hematol. 2022 Dec;97(12):1510-1519. doi: 10.1002/ajh.26709. Epub 2022 Oct 4. Am J Hematol. 2022. PMID: 36054786 Free PMC article. Clinical Trial.

4

Efficacy, safety, and survival findings after long-term follow-up of ZGJAK002: A phase 2 study comparing jaktinib at 100 mg twice daily (BID) and 200 mg once daily (QD) in patients with myelofibrosis.

Zhang Y, Zhou H, Jiang Z, Wu D, Zhuang J, Li W, Jiang Q, Wang X, Huang J, Zhu H, Yang L, Du X, Li F, Xia R, Zhang F, Hu J, Li Y, Hu Y, Liu J, Jin C, Sun K, Zhou Z, Wu L, Yin H, Suo S, Yu W, Jin J. Zhang Y, et al. Among authors: zhang f. Am J Hematol. 2024 Apr;99(4):774-779. doi: 10.1002/ajh.27245. Epub 2024 Feb 11. Am J Hematol. 2024. PMID: 38343062 Clinical Trial.

5

Treatment Effects of Integrated TCM and Western Medicine Treatment Scheme on COVID-19: A Single-armed Clinical Trial.

Bao J, Xie Z, Liu S, Huang L, Sun J, Tang Y, Chen H, Qi J, Guo J, Miao L, Li Z, Yang H, Zhang Y, Li Z, Xu Y, Lin S, Xun Y, Zhang L, Bao J, Cai Z, Huang J, Wen C. Bao J, et al. Among authors: zhang l, zhang y. Clin Complement Med Pharmacol. 2021 Dec;1(1):100009. doi: 10.1016/j.ccmp.2021.100009. Epub 2021 Nov 14. Clin Complement Med Pharmacol. 2021. PMID: 38620955 Free PMC article.

6

Transmembrane water-efflux rate measured by magnetic resonance imaging as a biomarker of the expression of aquaporin-4 in gliomas.

Jia Y, Xu S, Han G, Wang B, Wang Z, Lan C, Zhao P, Gao M, Zhang Y, Jiang W, Qiu B, Liu R, Hsu YC, Sun Y, Liu C, Liu Y, Bai R. Jia Y, et al. Among authors: zhang y. Nat Biomed Eng. 2023 Mar;7(3):236-252. doi: 10.1038/s41551-022-00960-9. Epub 2022 Nov 14. Nat Biomed Eng. 2023. PMID: 36376487

7

[Efficacy and Safety of Plerixafor Combined with G-CSF for Autologous Peripheral Blood Hematopoietic Stem Cell Mobilization in Lymphoma Patients].

Guan FS, He DH, Li Y, Zhang Y, Zheng GF, Zhu YY, He JS, Zhang EF, Cai Z, Zhao Y. Guan FS, et al. Among authors: zhang y, zhang ef. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Aug;31(4):1056-1060. doi: 10.19746/j.cnki.issn.1009-2137.2023.04.020. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023. PMID: 37551477 Chinese.

8

Efficacy and safety of tofacitinib combined with methotrexate in the treatment of rheumatoid arthritis: A systematic review and meta-analysis.

Gao Y, Gao YN, Wang MJ, Zhang Y, Zhang FQ, He ZX, Chen W, Li HC, Xie ZJ, Wen CP. Gao Y, et al. Among authors: zhang fq, zhang y. Heliyon. 2023 Apr 28;9(5):e15839. doi: 10.1016/j.heliyon.2023.e15839. eCollection 2023 May. Heliyon. 2023. PMID: 37215854 Free PMC article. Review.

9

miR-221-3p Delivered by BMMSC-Derived Microvesicles Promotes the Development of Acute Myelocytic Leukemia.

Zhang X, Xu Y, Wang J, Zhao S, Li J, Huang X, Xu H, Zhang X, Suo S, Lv Y, Zhang Y, Yu W. Zhang X, et al. Among authors: zhang y. Front Bioeng Biotechnol. 2020 Feb 14;8:81. doi: 10.3389/fbioe.2020.00081. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 32117949 Free PMC article.

10

Down-regulation of Musashi-2 exerts antileukemic effects on acute lymphoblastic leukemia cells and increases sensitivity to dexamethasone.

Zou D, Lv M, Chen Y, Niu T, Ma C, Shi C, Huang Z, Wu Y, Yang S, Wang Y, Wu N, Zhang Y, Ouyang G, Mu Q. Zou D, et al. Among authors: zhang y. Ann Hematol. 2024 Jan;103(1):141-151. doi: 10.1007/s00277-023-05468-z. Epub 2023 Sep 26. Ann Hematol. 2024. PMID: 37749318

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

239,010 results

Search Page